-transparent.png){kind=logo}
Methotrexate niosomes were formed by reverse phase evaporation technique using sorbitan monostearate (Span 60) surfactant. The pharmacokinetic parameters of methotrexate (MTX) after macrophage activation via muramyl dipeptide gelatin conjugate were studied and the results compared with those obtained after free MTX and MTX niosomes without macrophage activation. In mice MTX concentrations and tumour regression were higher after macrophage activation.
Related Publications
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
February 1982,
Gan,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
January 1975,
Neoplasma,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
December 1993,
Biological & pharmaceutical bulletin,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
January 1987,
Anticancer research,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
January 1988,
Medicina,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
April 1976,
Cancer research,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
October 1972,
Gan,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
December 2017,
Biomedical reports,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
January 1971,
Bollettino dell'Istituto sieroterapico milanese,
K S Chandraprakash, and
N Udupa, and
P Umadevi, and
G K Pillai
January 1949,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
